ID   A549 IFITM2/3-KO
AC   CVCL_B0A6
SY   C1-3
DR   cancercelllines; CVCL_B0A6
DR   Wikidata; Q108819811
RX   PubMed=30643282;
CC   Population: Caucasian.
CC   Characteristics: Has also reduced expression of IFITM1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 5413; IFITM2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 5414; IFITM3.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
RX   PubMed=30643282; DOI=10.1038/s41589-018-0213-2;
RA   Spence J.S., He R.-N., Hoffmann H.-H., Das T., Thinon E., Rice C.M.,
RA   Peng T., Chandran K., Hang H.C.;
RT   "IFITM3 directly engages and shuttles incoming virus particles to
RT   lysosomes.";
RL   Nat. Chem. Biol. 15:259-268(2019).
//